Topiramate-Induced Hair Loss: Case Report

The document reports a case of a 15-year-old girl with frontal lobe epilepsy who experienced hair loss after two months of topiramate adjunctive therapy. The hair loss was reversible when the drug was discontinued but recurred upon reintroduction. This suggests that hair loss should be considered a potential adverse effect of topiramate therapy. The case emphasizes the cosmetic and psychosocial impact of such side effects, particularly in children and young adults. The study involved only one patient, which limits the generalizability of the findings. However, it highlights the need for awareness among patients and clinicians regarding the possibility of hair loss with topiramate use.